MONOPAR THERAPEUTICS INC.
Last · NASDAQ$73.10+1.02 (+1.42%)close · yahoo · 17h ago
Market cap$490.66M6.7M sh
P/E · TTM-32.8fwd -38.2 · eps -2.23 · loss
Beta1.51vs S&P 500
Div yield0.00%annual · TTM
52w range
$50.07$124.82
Volume129.6Ksession
Loading chart…
Upcoming earnings
8:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.85
Est. revenue
0
Press & signals
- GlobeNewswire
Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026
- GlobeNewswire
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
- GlobeNewswire
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team